Pathogen burden, inflammation, proliferation and apoptosis in human in-stent restenosis: Tissue characteristics compared to primary atherosclerosis

Journal of Vascular Research

Volumn 41, Issue 6, 2004, Pages 525-534

  Skowasch, Dirk ^a   Jabs, Alexander ^a   Andrié, René ^a   Dinkelbach, Sabine ^a   Schiele, Thomas M ^b   Wernert, Nicolas ^a   Lüderitz, Berndt ^a   Bauriedel, Gerhard ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Apoptosis; In stent restenosis; Infection; Inflammation; Proliferation; Stents

Indexed keywords

C REACTIVE PROTEIN; CD40 ANTIGEN; CHLORDANE; HEAT SHOCK PROTEIN 60; KI 67 ANTIGEN;

ADULT; AGED; ANGINA PECTORIS; APOPTOSIS; ARTICLE; ATHERECTOMY; CELL DENSITY; CELL PROLIFERATION; CHLAMYDIASIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY STENT; CYTOMEGALOVIRUS; EPSTEIN BARR VIRUS; FEMALE; HELICOBACTER PYLORI; HERPES SIMPLEX VIRUS; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; MOLECULAR PROBE; NICK END LABELING; PATHOGENICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RESTENOSIS; VIRULENCE;

AGED; APOPTOSIS; ARTERIOSCLEROSIS; ATHERECTOMY, CORONARY; BIOLOGICAL MARKERS; CELL DIVISION; CHLAMYDIA INFECTIONS; CORONARY RESTENOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; STENTS; TUNICA INTIMA;

EID: 10644235403     PISSN: 10181172     EISSN: None     Source Type: Journal    
DOI: 10.1159/000081809     Document Type: Article

References (38)

1. Lowe H, Oesterle SN, Khachigian LM: Coronary in-stent restenosis: Current status and future strategies. J Am Coll Cardiol 2002;39:183-193.
2. Welt FGP, Rogers C: Inflammation and restenosis in the stent era. Arterioscler Thromb Vasc Biol 2002;22:1769-1776.
3. Ludewig B, Zinkernagel RM, Hengartner H: Arterial inflammation and atherosclerosis. Trends Cardiovasc Med 2002;12:154-159.
4. Chung I, Gold HK, Schwartz SM, Ikari Y, Reidy MA, Wight TN: Enhanced extracellular matrix accumulation in restenosis of coronary arteries after stent deployment. J Am Coll Cardiol 2002;40:2072-2081.
5. Moreno PR, Palacios IF, Leon MN, Rhodes J, Fuster V, Fallon JT: Histopathologic comparison of human coronary in-stent and post-balloon angioplasty restenotic tissue. Am J Cardiol 1999;84:462-466.
6. Skowasch D, Jabs A, Andrié R, Dinkelbach S, Lüderitz B, Bauriedel G: Presence of bone-marrow and neural-crest-derived cells in intimal hyperplasia at the time of clinical in-stent restenosis. Cardiovasc Res 2003;60:684-691.
7. Zohlnhöfer D, Klein CA, Richter T, Brandl R, Murr A, Nührenberg T, Schömig A, Baeuerle PA, Neumann FJ: Gene expression profiling of human stent-induced neointima by cDNA array analysis of microscopic specimens retrieved by helix cutter atherectomy. Detection of FK506-binding protein 12 upregulation. Circulation 2001;103:1396-1402.
8. Farb A, Sangiorgi G, Carter AJ, Walley VM, Edwards WD, Schwartz RS, Virmani R: Pathology of acute and chronic coronary stenting in humans. Circulation 1999;99:44-52.
9. Grewe PH, Deneke T, Machraoui A, Barmeyer J, Müller KM: Acute and chronic tissue response to coronary stent implantation: Pathologic findings in human specimen. J Am Coll Cardiol 2000;35:157-163.
10. Komatsu R, Ueda M, Naruko T, Kojima A, Becker AE: Neointimal tissue response at sites of coronary stenting in humans. Macroscopic, histological, and immunohistochemical analysis. Circulation 1998:98:224-233.
11. Kornowski R, Hong MK, Fermin OT, Bramwell O, Wu H, Leon MB: In-stent restenosis: Contributions of inflammatory responses and arterial injury to neointimal hyperplasia. J Am Coll Cardiol 1998;31:224-230.
12. Piek JJ, van der Wal AC, Meuwissen M, Koch KT, Chamuleau SA, Teeling P, van der Loos CM, Becker AE: Plaque inflammation in restenotic coronary lesions of patients with stable or unstable angina. J Am Coll Cardiol 2000;35:963-967.
13. Farb A, Weber DK, Kolodgie FD, Burke AP, Virmani R: Morphological predictors of restenosis after coronary stenting in humans. Circulation 2002;105:2974-2980.
14. Epstein SE, Zhu J, Burnett MS, Zhou YF, Vercellotti G, Hahhar D: Infection and atherosclerosis. Potential roles of pathogen burden and molecular mimicry. Arterioscler Thromb Vasc Biol 2000;20:1417-1420.
15. Horne BD, Muhlestein JB, Strobel GG, Carlquist JF, Bair TL, Anderson JL: Greater pathogen burden but not elevated C-reactive protein increases the risk of clinical restenosis after percutaneous coronary intervention. Am Heart J 2002;144:491-500.
16. Neumann FJ, Kastrati A, Miethke T, Mehilli J, Pogatsa-Murray G, Koch W, Seyfarth M, Schömig A: Previous cytomegalovirus infection and restenosis after coronary stent placement. Circulation 2001;104:1135-1139.
17. Neumann FJ, Kastrati A, Miethke T, Pogatsa-Murray G, Mehilli J, Valina C, Jogethaei N, da Costa CP, Wagner H, Schömig A: Treatment of Chlamydia pneumoniae infection with roxithromycin and effect on neointima proliferation after coronary stent placement (ISAR-3): A randomized, double blind, placebo-controlled trial. Lancet 2001;357:2085-2089.
18. Saikku P, Leinonen M, Mattila K, Ekman MR, Nieminen MS, Makela PH, Huttunen JK, Valtonen V: Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988;2:983-986.
19. Zhou YF, Leon MB, Waclawiw MA, Popma JJ, Yu ZX, Finkel T, Epstein SE: Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N Engl J Med 1996;335:624-630.
20. Mayr M, Kiechl S, Willeit J, Wick J, Xu Q: Infections, immunity, and atherosclerosis. Associations of antibodies to Chlamydia pneumoniae, Helicobacter pylori, and cytomegalovirus with immune reactions to heat-shock protein 60 and carotid or femoral atherosclerosis. Circulation 2000;102:833-839.
21. O'Brien ER, Alpers CE, Stewart DK, Ferguson M, Tran N, Gordon D, Benditt EP, Hinohara T, Simpson JB, Schwartz SM: Proliferation in primary and restenotic coronary atherectomy tissue: Implications for antiproliferative therapy. Circ Res 1993;73:223-231.
22. Pickering JG, Weir L, Jekanowsk J, Kearny MA, Isner JM: Proliferative activity in peripheral and coronary atherosclerotic plaque among patients undergoing percutaneous revascularization. J Clin Invest 1993;91:1469-1480.
23. Bauriedel G, Schluckebier S, Hutter R, Welsch U, Kandolf R, Lüderitz B, Prescott MF: Apoptosis in restenosis versus stable-angina atherosclerosis: Implications for the pathogenesis of restenosis. Arterioscler Thromb Vasc Biol 1998;18:1132-1139.
24. Abdelmegui AE, Ellis SG, Sapp SK, Simpendorfer C, Franco I, Whitlow PL: Directional atherectomy in unstable angina. J Am Coll Cardiol 1994;24:46-54.
25. Simonton CA, Leon MB, Baim DS, Hinohara T, Kent KM, Bersin RM, Wilson BH, Mintz GS, Fitzgerald PJ, Yock PG, Popma JJ, Ho KK, Cutlip DE, Senerchia C, Kuntz RE: Optimal directional coronary atherectomy. Final results of the optimal atherectomy restenosis study (OARS). Circulation 1998;97:332-339.
26. Kol A, Bourcier T, Lichtman AH, Libby P: Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages. J Clin Invest 1999;103:571-577.
27. Chiu B: Multiple infections in carotid atherosclerotic plaque. Am Heart J 1999;138:S534-S536.
28. Arbustini E, De Servi S, Bramucci E, Porcu E, Costante AM, Grasso M, Diegoli M, Fasani R, Morbini P, Angoli L: Comparison of coronary lesions obtained by directional coronary atherectomy in unstable angina, stable angina and restenosis after either atherectomy or angioplasty. Am J Cardiol 1995;75:675-682.
29. Moreno PR, Bernardi VH, Lopez-Cuellar J, Newell JB, McMellon C, Gold HK, Palacios IF, Fuster V, Fallon JT: Macrophage infiltration predicts restenosis after coronary intervention in patients with unstable angina. Circulation 1996;94:3098-3102.
30. Buffon A, Liuzzo G, Biasucci LM, Pasqualetti P, Ramazzotti V, Rebuzzi AG, Crea F, Maseri A: Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplasty. J Am Coll Cardiol 1999;34:1512-1521.
31. Lutgens E, Daemen JAP: CD40-CD40L interactions in atherosclerosis. Trends Cardiovasc Med 2002;12:27-32.
32. Han CL, Campbell GR, Campbell JH: Circulating bone marrow cells can contribute to neointimal formation. J Vasc Res 2001;38:113-119.
33. Bauriedel G, Jabs A, Skowasch D, Hutter R, Badimon JJ, Fuster V, Welsch U, Lüderitz B: Dendritic cells in neointima formation after rat carotid balloon injury. Coordinated expression with anti-apoptotic Bcl-2 and HSP47 in arterial repair. J Am Coll Cardiol 2003;42:930-938.
34. Bauriedel G, Schmücking I, Schmidt T, Braun P, Park JW, Heinrich KW, Lüderitz B: Intimal cell density in postangioplasty versus primary coronary and peripheral lesions: A systematic study on human atherectomy samples. J Interven Cardiol 1997;10:417-425.
35. Kearney M, Pieczek A, Haley L, Losordo DW, Andres V, Schainfeld R, Rosenfield K, Isner JM: Histopathology of in-stent restenosis in patients with peripheral artery disease. Circulation 1997;95:1998-2002.
36. Carter AJ, Laird JR, Farb A, Kufs W, Wortham DC, Virmani R: Morphologic characteristics of lesion formation in a porcine proliferative restenosis model. J Am Coll Cardiol 1994;24:1398-1405.
37. Schönbeck U, Libby P: Inflammation, immunity, and HMG-CoA reductase inhibitors. Statins as anti-inflammatory agents? Circulation 2004;109(suppl II):II-18-II-26.
38. Lévy BI: Can angiotensin II type 2 receptors have deleterious effects in cardiovascular disease? Implications for therapeutic blockade of the rennin-angiotensin system. Circulation 2004;109:8-13.